Nirmatrelvir/ritonavir: Efficacy, safety and drug monitoring in a real-life cohort of outpatient liver transplant recipients - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Nirmatrelvir/ritonavir: Efficacy, safety and drug monitoring in a real-life cohort of outpatient liver transplant recipients

Fichier non déposé

Dates et versions

hal-04286518 , version 1 (15-11-2023)

Identifiants

  • HAL Id : hal-04286518 , version 1

Citer

C. Tron, B. Giguet, C. Rayer, C. Jézéquel, M. C Verdier, et al.. Nirmatrelvir/ritonavir: Efficacy, safety and drug monitoring in a real-life cohort of outpatient liver transplant recipients. Annual Meeting of French Society of Pharmacology and Therapeutics, Jun 2023, Limoges, France. ⟨hal-04286518⟩
14 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More